Chapman, M.S., Cirulli, J. and McBride, S. 2018. Sustained Improvement in Patient-Reported Outcomes with Continued Apremilast Treatment over 104 Weeks in Patients with Moderate to Severe Psoriasis. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S23. DOI:https://doi.org/10.25251/skin.2.supp.23.